Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders

Abbott, 2006, Astrocyte-endothelial interactions at the blood-brain barrier, Nat Rev Neurosci., 7, 41, 10.1038/nrn1824 Abbott, 2010, Structure and function of the blood-brain barrier, Neurobiol Dis., 37, 13, 10.1016/j.nbd.2009.07.030 Abbott, 2013, Blood-brain barrier structure and function and the challenges for CNS drug delivery, J Inherit Metab Dis., 36, 437, 10.1007/s10545-013-9608-0 Abuznait, 2012, Role of ABC transporters in the pathogenesis of Alzheimer׳s disease, ACS Chem Neurosci, 3, 820, 10.1021/cn300077c Abuznait, 2013, Olive-oil-derived oleocanthal enhances beta-amyloid clearance as a potential neuroprotective mechanism against Alzheimer׳s disease: in vitro and in vivo studies, ACS Chem Neurosci, 4, 973, 10.1021/cn400024q Agarwal, 2010, Distribution of gefitinib to the brain is limited by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)-mediated active efflux, J Pharmacol Exp Ther., 334, 147, 10.1124/jpet.110.167601 Agarwal, 2011, Breast cancer resistance protein and P-glycoprotein in brain cancer: two gatekeepers team up, Curr Pharm Des, 17, 2793, 10.2174/138161211797440186 Ahmed, 2005, Epileptic seizures and epilepsy, Epilepsia., 46, 1701, 10.1111/j.1528-1167.2005.00273_3.x Ak, 2007, Expression and cellular distribution of multidrug resistance-related proteins in patients with focal cortical dysplasia, Seizure, 16, 493, 10.1016/j.seizure.2007.03.011 Aller, 2009, Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding, Science, 323, 1718, 10.1126/science.1168750 Aronica, 2003, Expression and cellular distribution of multidrug transporter proteins in two major causes of medically intractable epilepsy: focal cortical dysplasia and glioneuronal tumors, Neuroscience, 118, 417, 10.1016/S0306-4522(02)00992-2 Aronica, 2005, Localization of breast cancer resistance protein (BCRP) in microvessel endothelium of human control and epileptic brain, Epilepsia, 46, 849, 10.1111/j.1528-1167.2005.66604.x Aronica, 2012, Cerebral expression of drug transporters in epilepsy, Adv Drug Deliv Rev., 64, 919, 10.1016/j.addr.2011.11.008 Ashraf, 2011, Regulation of P-glycoprotein by human immunodeficiency virus-1 in primary cultures of human fetal astrocytes, J Neurosci Res., 89, 1773, 10.1002/jnr.22720 Aye, 2013, Placental ABC transporters, cellular toxicity and stress in pregnancy, Chem Biol Interact., 203, 456, 10.1016/j.cbi.2013.03.007 Ballabh, 2004, The blood-brain barrier: an overview: structure, regulation, and clinical implications, Neurobiol Dis., 16, 1, 10.1016/j.nbd.2003.12.016 Barakat, 2007, Modulation of p-glycoprotein function by caveolin-1 phosphorylation, J Neurochem., 101, 1, 10.1111/j.1471-4159.2006.04410.x Barnes, 2003, Ionotropic glutamate receptor biology: effect on synaptic connectivity and function in neurological disease, Curr Med Chem., 10, 2059, 10.2174/0929867033456800 Battle, 2013, Diagnostic and Statistical Manual of Mental Disorders (DSM), Codas, 25, 191 Bauer, 2006, In vivo activation of human pregnane X receptor tightens the blood-brain barrier to methadone through P-glycoprotein up-regulation, Mol Pharmacol., 70, 1212, 10.1124/mol.106.023796 Bauer, 2007, Tumor necrosis factor alpha and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier, Mol Pharmacol., 71, 667, 10.1124/mol.106.029512 Bauer, 2008, Seizure-induced up-regulation of P-glycoprotein at the blood-brain barrier through glutamate and cyclooxygenase-2 signaling, Mol Pharmacol., 73, 1444, 10.1124/mol.107.041210 Becker, 1991, The multidrug-resistance gene MDR1 is expressed in human glial tumors, Acta Neuropathol., 82, 516, 10.1007/BF00293387 Begley, 2004, ABC transporters and the blood-brain barrier, Current Pharmaceutical Design., 10, 1295, 10.2174/1381612043384844 Block, 2004, Nanometer size diesel exhaust particles are selectively toxic to dopaminergic neurons: the role of microglia, phagocytosis, and NADPH oxidase, FASEB J, 18, 1618, 10.1096/fj.04-1945fje Brandt, 2006, The multidrug transporter hypothesis of drug resistance in epilepsy: Proof-of-principle in a rat model of temporal lobe epilepsy, Neurobiol Dis., 24, 202, 10.1016/j.nbd.2006.06.014 Brenn, 2014, St. John׳s Wort reduces beta-amyloid accumulation in a double transgenic Alzheimer׳s disease mouse model-role of P-glycoprotein, Brain Pathol., 24, 18, 10.1111/bpa.12069 Calderon-Garciduenas, 2004, Brain inflammation and Alzheimer׳s-like pathology in individuals exposed to severe air pollution, Toxicol Pathol., 32, 650, 10.1080/01926230490520232 Campos, 2012, ABC transporter function and regulation at the blood-spinal cord barrier, J Cereb Blood Flow Metab., 32, 1559, 10.1038/jcbfm.2012.47 Candela, 2010, Apical-to-basolateral transport of amyloid-beta peptides through blood-brain barrier cells is mediated by the receptor for advanced glycation end-products and is restricted by P-glycoprotein, J Alzheimers Dis., 22, 849, 10.3233/JAD-2010-100462 Cannon, 2012, Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain, Proc Natl Acad Sci U S A, 109, 15930, 10.1073/pnas.1203534109 Carrano, 2011, Amyloid Beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy, Antioxid Redox Signal., 15, 1167, 10.1089/ars.2011.3895 Cartwright, 2013, Mrp1 is essential for sphingolipid signaling to p-glycoprotein in mouse blood-brain and blood-spinal cord barriers, J Cereb Blood Flow Metab., 33, 381, 10.1038/jcbfm.2012.174 Cecchelli, 2007, Modelling of the blood-brain barrier in drug discovery and development, Nat Rev Drug Discov., 6, 650, 10.1038/nrd2368 Cen, 2013, Alteration in P-glycoprotein at the blood-brain barrier in the early period of MCAO in rats, J Pharm Pharmacol., 65, 665, 10.1111/jphp.12033 Chakravarty, 2005, Toll-like receptor 4 on nonhematopoietic cells sustains CNS inflammation during endotoxemia, independent of systemic cytokines, J Neurosci., 25, 1788, 10.1523/JNEUROSCI.4268-04.2005 Chan, 2011, ATP-binding cassette transporters in inflammatory brain disease, Curr Pharm Des, 17, 2803, 10.2174/138161211797440131 Chan, 2013, Induction of P-glycoprotein by antiretroviral drugs in human brain microvessel endothelial cells, Antimicrob Agents Chemother., 57, 4481, 10.1128/AAC.00486-13 Chang, 2007, A molecular understanding of ATP-dependent solute transport by multidrug resistance-associated protein MRP1, Cancer Metastasis Rev., 26, 15, 10.1007/s10555-007-9041-7 Choi, 2014, ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development, Curr Pharm Des, 20, 793, 10.2174/138161282005140214165212 Cirrito, 2005, P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model, J Clin Invest., 115, 3285, 10.1172/JCI25247 Citron, 2010, Alzheimer׳s disease: strategies for disease modification, Nat Rev Drug Discov., 9, 387, 10.1038/nrd2896 Dallas, 2003, Functional expression of the multidrug resistance protein 1 in microglia, J Pharmacol Exp Ther., 307, 282, 10.1124/jpet.103.054304 Dallas, 2006, Multidrug resistance-associated proteins: expression and function in the central nervous system, Pharmacol Rev., 58, 140, 10.1124/pr.58.2.3 Daood, 2008, ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNS, Neuropediatrics, 39, 211, 10.1055/s-0028-1103272 Dauchy, 2008, ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier, J Neurochem., 107, 1518, 10.1111/j.1471-4159.2008.05720.x Dazert, 2006, Differential regulation of transport proteins in the periinfarct region following reversible middle cerebral artery occlusion in rats, Neuroscience, 142, 1071, 10.1016/j.neuroscience.2006.07.056 de Klerk, 2009, Locally increased P-glycoprotein function in major depression: a PET study with [11C]verapamil as a probe for P-glycoprotein function in the blood-brain barrier, Int J Neuropsychopharmacol., 12, 895, 10.1017/S1461145709009894 de Klerk, 2010, Regional increase in P-glycoprotein function in the blood-brain barrier of patients with chronic schizophrenia: a PET study with [(11)C]verapamil as a probe for P-glycoprotein function, Psychiatry Res., 183, 151, 10.1016/j.pscychresns.2010.05.002 Decleves, 2000, Functional expression of P-glycoprotein and multidrug resistance-associated protein (Mrp1) in primary cultures of rat astrocytes, J Neurosci Res., 60, 594, 10.1002/(SICI)1097-4547(20000601)60:5<594::AID-JNR4>3.0.CO;2-6 Decleves, 2002, Molecular and functional MDR1-Pgp and MRPs expression in human glioblastoma multiforme cell lines, Int J Cancer., 98, 173, 10.1002/ijc.10135 Deeken, 2007, The blood-brain barrier and cancer: transporters, treatment, and Trojan horses, Clin Cancer Res., 13, 1663, 10.1158/1078-0432.CCR-06-2854 Diop, 2005, N-Linked glycosylation of the human ABC transporter ABCG2 on asparagine 596 is not essential for expression, transport activity, or trafficking to the plasma membrane, Biochemistry, 44, 5420, 10.1021/bi0479858 Dirnagl, 1999, Pathobiology of ischaemic stroke: an integrated view, Trends Neurosci., 22, 391, 10.1016/S0166-2236(99)01401-0 Do, 2012, ABCG2- and ABCG4-mediated efflux of amyloid-beta peptide 1-40 at the mouse blood-brain barrier, J Alzheimers Dis., 30, 155, 10.3233/JAD-2012-112189 Douek, 2009, Emerging concepts in the immunopathogenesis of AIDS, Annu Rev Med., 60, 471, 10.1146/annurev.med.60.041807.123549 Driessen, 2010, Cognitive behavioral therapy for mood disorders: efficacy, moderators and mediators, Psychiatr Clin North Am., 33, 537, 10.1016/j.psc.2010.04.005 Eisenblatter, 2003, Characterisation of the brain multidrug resistance protein (BMDP/ABCG2/BCRP) expressed at the blood-brain barrier, Brain Res., 971, 221, 10.1016/S0006-8993(03)02401-6 ElAli, 2010, Apolipoprotein E controls ATP-binding cassette transporters in the ischemic brain, Sci Signal., 3, 10.1126/scisignal.2001213 Enerson, 2006, The rat blood-brain barrier transcriptome, J Cereb Blood Flow Metab., 26, 959, 10.1038/sj.jcbfm.9600249 Felix, 2002, P-glycoprotein expression in rat brain endothelial cells: evidence for regulation by transient oxidative stress, J Neurochem., 80, 64, 10.1046/j.0022-3042.2001.00660.x Ferrara, 2002, VEGF and the quest for tumour angiogenesis factors, Nat Rev Cancer., 2, 795, 10.1038/nrc909 Frohman, 2006, Multiple sclerosis--the plaque and its pathogenesis, N Engl J Med., 354, 942, 10.1056/NEJMra052130 Fu, 2012, Intracellular trafficking of P-glycoprotein, Int J Biochem Cell Biol., 44, 461, 10.1016/j.biocel.2011.12.009 Garbuzova-Davis, 2014, Blood-CNS Barrier Impairment in ALS patients versus an animal model, Front Cell Neurosci, 8, 21, 10.3389/fncel.2014.00021 Gazzin, 2008, Differential expression of the multidrug resistance-related proteins ABCb1 and ABCc1 between blood-brain interfaces, J Comp Neurol., 510, 497, 10.1002/cne.21808 Gazzin, 2011, Modulation of Mrp1 (ABCc1) and Pgp (ABCb1) by bilirubin at the blood-CSF and blood-brain barriers in the Gunn rat, PLoS One, 6, e16165, 10.1371/journal.pone.0016165 Gonzalez-Scarano, 2005, The neuropathogenesis of AIDS, Nat Rev Immunol., 5, 69, 10.1038/nri1527 Haar, 2012, Drug resistance in glioblastoma: a mini review, Neurochem Res., 37, 1192, 10.1007/s11064-011-0701-1 Haber, 2006, Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma, J Clin Oncol., 24, 1546, 10.1200/JCO.2005.01.6196 Haga, 2001, Involvement of the multidrug resistance protein 3 in drug sensitivity and its expression in human glioma, Jpn J Cancer Res., 92, 211, 10.1111/j.1349-7006.2001.tb01084.x Hartz, 2004, Rapid regulation of P-glycoprotein at the blood-brain barrier by endothelin-1, Mol Pharmacol., 66, 387, 10.1124/mol.104.001503 Hartz, 2006, Rapid modulation of P-glycoprotein-mediated transport at the blood-brain barrier by tumor necrosis factor-alpha and lipopolysaccharide, Mol Pharmacol., 69, 462, 10.1124/mol.105.017954 Hartz, 2008, Diesel exhaust particles induce oxidative stress, proinflammatory signaling, and P-glycoprotein up-regulation at the blood-brain barrier, FASEB J, 22, 2723, 10.1096/fj.08-106997 Hartz, 2010, Estrogen receptor beta signaling through phosphatase and tensin homolog/phosphoinositide 3-kinase/Akt/glycogen synthase kinase 3 down-regulates blood-brain barrier breast cancer resistance protein, J Pharmacol Exp Ther., 334, 467, 10.1124/jpet.110.168930 Hartz, 2010, 17-beta-Estradiol: a powerful modulator of blood-brain barrier BCRP activity, J Cereb Blood Flow Metab., 30, 1742, 10.1038/jcbfm.2010.36 Hartz, 2010, Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer׳s disease, Mol Pharmacol., 77, 715, 10.1124/mol.109.061754 Hartz, 2011, ABC transporters in the CNS - an inventory, Curr Pharm Biotechnol., 12, 656, 10.2174/138920111795164020 Hawkins, 2005, The blood-brain barrier/neurovascular unit in health and disease, Pharmacol Rev., 57, 173, 10.1124/pr.57.2.4 Hawkins, 2010, Rapid loss of blood-brain barrier P-glycoprotein activity through transporter internalization demonstrated using a novel in situ proteolysis protection assay, J Cereb Blood Flow Metab., 30, 1593, 10.1038/jcbfm.2010.117 Hawkins, 2010, Rapid, reversible modulation of blood-brain barrier P-glycoprotein transport activity by vascular endothelial growth factor, J Neurosci., 30, 1417, 10.1523/JNEUROSCI.5103-09.2010 Hayashi, 2005, HIV-Tat protein induces P-glycoprotein expression in brain microvascular endothelial cells, J Neurochem., 93, 1231, 10.1111/j.1471-4159.2005.03114.x Hayashi, 2006, HIV-TAT protein upregulates expression of multidrug resistance protein 1 in the blood-brain barrier, J Cereb Blood Flow Metab., 26, 1052, 10.1038/sj.jcbfm.9600254 Hayden, 2012, NF-kappaB, the first quarter-century: remarkable progress and outstanding questions, Genes Dev., 26, 203, 10.1101/gad.183434.111 Heneka, 2015, Neuroinflammation in Alzheimer׳s disease, Lancet Neurol., 14, 388, 10.1016/S1474-4422(15)70016-5 Hennessy, 2007, A primer on the mechanics of P-glycoprotein the multidrug transporter, Pharmacological Research., 55, 1, 10.1016/j.phrs.2006.10.007 Hermann, 2006, Role of drug efflux carriers in the healthy and diseased brain, Ann Neurol., 60, 489, 10.1002/ana.21012 Hirrlinger, 2002, Expression of mRNAs of multidrug resistance proteins (Mrps) in cultured rat astrocytes, oligodendrocytes, microglial cells and neurones, J Neurochem., 82, 716, 10.1046/j.1471-4159.2002.01082.x Iqbal, 2012, Pro-inflammatory cytokine regulation of P-glycoprotein in the developing blood-brain barrier, PLoS One, 7, e43022, 10.1371/journal.pone.0043022 Ironside, 2008, Biology and neuropathology of prion diseases, Handb Clin Neurol, 89, 779, 10.1016/S0072-9752(07)01268-7 Jablonski, 2012, Selective increase of two ABC drug efflux transporters at the blood-spinal cord barrier suggests induced pharmacoresistance in ALS, Neurobiol Dis., 47, 194, 10.1016/j.nbd.2012.03.040 Jablonski, 2014, Inhibiting drug efflux transporters improves efficacy of ALS therapeutics, Ann Clin Transl Neurol, 1, 996, 10.1002/acn3.141 Jodoin, 2003, P-glycoprotein in blood-brain barrier endothelial cells: interaction and oligomerization with caveolins, J Neurochem., 87, 1010, 10.1046/j.1471-4159.2003.02081.x Kalia, 2015, Parkinson׳s disease, Lancet, 10.1016/S0140-6736(14)61393-3 Kamar, 2010, Brain metastases, Semin Neurol., 30, 217, 10.1055/s-0030-1255225 Kamiie, 2008, Quantitative atlas of membrane transporter proteins: development and application of a highly sensitive simultaneous LC/MS/MS method combined with novel in-silico peptide selection criteria, Pharm Res., 25, 1469, 10.1007/s11095-008-9532-4 Kania, 2011, Beta amyloid effects on expression of multidrug efflux transporters in brain endothelial cells, Brain Res., 1418, 1, 10.1016/j.brainres.2011.08.044 Kilic, 2008, ABCC1: a gateway for pharmacological compounds to the ischaemic brain, Brain, 131, 2679, 10.1093/brain/awn222 Kim, 2009, Lack of association between ABCB1, ABCG2, and ABCC2 genetic polymorphisms and multidrug resistance in partial epilepsy, Epilepsy Res., 84, 86, 10.1016/j.eplepsyres.2008.12.001 Konsman, 2004, Rat brain vascular distribution of interleukin-1 type-1 receptor immunoreactivity: relationship to patterns of inducible cyclooxygenase expression by peripheral inflammatory stimuli, J Comp Neurol., 472, 113, 10.1002/cne.20052 Kooij, 2010, T lymphocytes impair P-glycoprotein function during neuroinflammation, J Autoimmun., 34, 416, 10.1016/j.jaut.2009.10.006 Kooij, 2011, Adenosine triphosphate-binding cassette transporters mediate chemokine (C-C motif) ligand 2 secretion from reactive astrocytes: relevance to multiple sclerosis pathogenesis, Brain, 134, 555, 10.1093/brain/awq330 Kortekaas, 2005, Blood-brain barrier dysfunction in parkinsonian midbrain in vivo, Ann Neurol., 57, 176, 10.1002/ana.20369 Kotsopoulos, 2005, Incidence of epilepsy and predictive factors of epileptic and non-epileptic seizures, Seizure, 14, 175, 10.1016/j.seizure.2005.01.005 Krohn, 2011, Cerebral amyloid-beta proteostasis is regulated by the membrane transport protein ABCC1 in mice, J Clin Invest., 121, 3924, 10.1172/JCI57867 Kruh, 2003, The MRP family of drug efflux pumps, Oncogene, 22, 7537, 10.1038/sj.onc.1206953 Kuhnke, 2007, MDR1-P-Glycoprotein (ABCB1) Mediates Transport of Alzheimer׳s amyloid-beta peptides--implications for the mechanisms of Abeta clearance at the blood-brain barrier, Brain Pathol., 17, 347, 10.1111/j.1750-3639.2007.00075.x Lazarowski, 2007, ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy, Epilepsia, 48, 140, 10.1111/j.1528-1167.2007.01302.x Ledoux, 2003, Glucose depletion enhances P-glycoprotein expression in hepatoma cells: role of endoplasmic reticulum stress response, Cancer Res., 63, 7284 Lee, 2007, Expression of the ATP-binding cassette membrane transporter, ABCG2, in human and rodent brain microvessel endothelial and glial cell culture systems, Pharm Res., 24, 1262, 10.1007/s11095-007-9244-1 Leslie, 2005, Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense, Toxicol Appl Pharmacol., 204, 216, 10.1016/j.taap.2004.10.012 Li, 2002, Reactive species mechanisms of cellular hypoxia-reoxygenation injury, Am J Physiol Cell Physiol, 282, C227, 10.1152/ajpcell.00112.2001 Lin, 2014, ABCB1, ABCG2, and PTEN determine the response of glioblastoma to temozolomide and ABT-888 therapy, Clin Cancer Res., 20, 2703, 10.1158/1078-0432.CCR-14-0084 Liu, 2013, Pesticide-induced gene mutations and Parkinson disease risk: a meta-analysis, Genet Test Mol Biomarkers, 17, 826, 10.1089/gtmb.2013.0313 Loscher, 2005, Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases, Prog Neurobiol., 76, 22, 10.1016/j.pneurobio.2005.04.006 Loscher, 2005, Blood-brain barrier active efflux transporters: ATP-binding cassette gene family, NeuroRx, 2, 86, 10.1602/neurorx.2.1.86 Loscher, 2005, Drug resistance in brain diseases and the role of drug efflux transporters, Nat Rev Neurosci., 6, 591, 10.1038/nrn1728 Luna-Munguia, 2015, Glutamate-mediated upregulation of the multidrug resistance protein 2 in porcine and human brain capillaries, J Pharmacol Exp Ther., 352, 368, 10.1124/jpet.114.218180 Luna-Tortos, 2008, Several major antiepileptic drugs are substrates for human P-glycoprotein, Neuropharmacology, 55, 1364, 10.1016/j.neuropharm.2008.08.032 Mahringer, 2010, BCRP at the blood-brain barrier: genomic regulation by 17beta-estradiol, Mol Pharm., 7, 1835, 10.1021/mp1001729 Maliepaard, 2001, Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues, Cancer Res., 61, 3458 Mao, 2015, Role of the breast cancer resistance protein (BCRP/ABCG2) in drug transport--an update, AAPS J., 17, 65, 10.1208/s12248-014-9668-6 Milane, 2007, Minocycline and riluzole brain disposition: interactions with p-glycoprotein at the blood-brain barrier, J Neurochem., 103, 164 Miller, 2008, Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy, Pharmacol Rev., 60, 196, 10.1124/pr.107.07109 Miller, 2010, Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier, Trends Pharmacol Sci., 31, 246, 10.1016/j.tips.2010.03.003 Miller, 2014, ABC transporter regulation by signaling at the blood-brain barrier: relevance to pharmacology, Adv Pharmacol., 71, 1, 10.1016/bs.apha.2014.06.008 Miller, 2015, Regulation of ABC transporters at the blood-brain barrier, Clin Pharmacol Ther., 97, 395, 10.1002/cpt.64 Moitra, 2011, Evolution of ABC transporters by gene duplication and their role in human disease, Biol Chem., 392, 29, 10.1515/bc.2011.006 Nadeau, 1999, Effects of circulating tumor necrosis factor on the neuronal activity and expression of the genes encoding the tumor necrosis factor receptors (p55 and p75) in the rat brain: a view from the blood-brain barrier, Neuroscience, 93, 1449, 10.1016/S0306-4522(99)00225-0 Narang, 2008, Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier, Am J Physiol Cell Physiol, 295, C440, 10.1152/ajpcell.00491.2007 Nel, 2005, Atmosphere. Air pollution-related illness: effects of particles, Science, 308, 804, 10.1126/science.1108752 Nguyen, 2002, Innate immunity: the missing link in neuroprotection and neurodegeneration?, Nat Rev Neurosci, 3, 216, 10.1038/nrn752 Nies, 2004, Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain, Neuroscience, 129, 349, 10.1016/j.neuroscience.2004.07.051 Novac, 2004, Nuclear receptors: overview and classification, Curr Drug Targets Inflamm Allergy, 3, 335, 10.2174/1568010042634541 Nwaozuzu, 2003, Signalling pathways influencing basal and H(2)O(2)-induced P-glycoprotein expression in endothelial cells derived from the blood-brain barrier, J Neurochem., 87, 1043, 10.1046/j.1471-4159.2003.02061.x Olefsky, 2001, Nuclear receptor minireview series, J Biol Chem., 276, 36863, 10.1074/jbc.R100047200 Oude Elferink, 2007, Transporters in the intestine limiting drug and toxin absorption, J Physiol Biochem., 63, 75, 10.1007/BF03174087 Park, 2014, Abeta1-42 reduces P-glycoprotein in the blood-brain barrier through RAGE-NF-kappaB signaling, Cell Death Dis, 5, e1299, 10.1038/cddis.2014.258 Parrish, 2015, Improving drug delivery to primary and metastatic brain tumors: strategies to overcome the blood-brain barrier, Clin Pharmacol Ther., 97, 336, 10.1002/cpt.71 Patak, 2011, ATP-binding cassette transporters at the blood-brain barrier in ischaemic stroke, Curr Pharm Des, 17, 2787, 10.2174/138161211797440195 Patak, 2011, The ATP-binding cassette transporters ABCB1 and ABCC1 are not regulated by hypoxia in immortalised human brain microvascular endothelial cells, Exp Transl Stroke Med, 3, 12, 10.1186/2040-7378-3-12 Pekcec, 2009, Targeting prostaglandin E2 EP1 receptors prevents seizure-associated P-glycoprotein up-regulation, J Pharmacol Exp Ther., 330, 939, 10.1124/jpet.109.152520 Perego, 2010, The ABC of glycosylation, Nat Rev Cancer., 10, 523, 10.1038/nrc2789-c1 Pilorget, 2007, Modulation of P-glycoprotein function by sphingosine kinase-1 in brain endothelial cells, J Neurochem., 100, 1203, 10.1111/j.1471-4159.2006.04295.x Pinzon-Daza, 2014, The cross-talk between canonical and non-canonical Wnt-dependent pathways regulates P-glycoprotein expression in human blood-brain barrier cells, J Cereb Blood Flow Metab., 34, 1258, 10.1038/jcbfm.2014.100 Poller, 2010, Regulation of BCRP (ABCG2) and P-glycoprotein (ABCB1) by cytokines in a model of the human blood-brain barrier, Cell Mol Neurobiol., 30, 63, 10.1007/s10571-009-9431-1 Potschka, 2010, Modulating P-glycoprotein regulation: future perspectives for pharmacoresistant epilepsies?, Epilepsia, 51, 1333, 10.1111/j.1528-1167.2010.02585.x Potschka, 2010, Targeting regulation of ABC efflux transporters in brain diseases: a novel therapeutic approach, Pharmacol Ther., 125, 118, 10.1016/j.pharmthera.2009.10.004 Pratt, 2012, Amyotrophic lateral sclerosis: update and new developments, Degener Neurol Neuromuscul Dis, 2012, 1 Qosa, 2012, Enhanced brain amyloid-beta clearance by rifampicin and caffeine as a possible protective mechanism against Alzheimer׳s disease, J Alzheimers Dis., 31, 151, 10.3233/JAD-2012-120319 Qosa, 2014, Differences in amyloid-beta clearance across mouse and human blood-brain barrier models: Kinetic analysis and mechanistic modeling, Neuropharmacology, 79C, 668, 10.1016/j.neuropharm.2014.01.023 Qosa, 2014, Mixed oligomers and monomeric amyloid-beta disrupts endothelial cells integrity and reduces monomeric amyloid-beta transport across hCMEC/D3 cell line as an in vitro blood-brain barrier model, Biochim Biophys Acta., 1842, 1806, 10.1016/j.bbadis.2014.06.029 Rao, 1999, Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier, Proc Natl Acad Sci U S A, 96, 3900, 10.1073/pnas.96.7.3900 Rapposelli, 2009, P-gp transporter and its role in neurodegenerative diseases, Curr Top Med Chem., 9, 209, 10.2174/156802609787521544 Regina, 2001, Multidrug resistance in brain tumors: roles of the blood-brain barrier, Cancer Metastasis Rev., 20, 13, 10.1023/A:1013104423154 Ribatti, 2006, Development of the blood-brain barrier: a historical point of view, Anat Rec B New Anat, 289, 3, 10.1002/ar.b.20087 Rigor, 2010, Activation of PKC isoform beta(I) at the blood-brain barrier rapidly decreases P-glycoprotein activity and enhances drug delivery to the brain, J Cereb Blood Flow Metab., 30, 1373, 10.1038/jcbfm.2010.21 Rivest, 2003, Molecular insights on the cerebral innate immune system, Brain Behav Immun., 17, 13, 10.1016/S0889-1591(02)00055-7 Robertson, 2009, P-glycoprotein expression in immortalised rat brain endothelial cells: comparisons following exogenously applied hydrogen peroxide and after hypoxia-reoxygenation, J Neurochem., 111, 132, 10.1111/j.1471-4159.2009.06306.x Robertson, 2011, Nitric oxide contributes to hypoxia-reoxygenation-induced P-glycoprotein expression in rat brain endothelial cells, Cell Mol Neurobiol., 31, 1103, 10.1007/s10571-011-9711-4 Robillard, 2012, Expression of ATP-binding cassette membrane transporters in rodent and human sertoli cells: relevance to the permeability of antiretroviral therapy at the blood-testis barrier, J Pharmacol Exp Ther., 340, 96, 10.1124/jpet.111.186916 Ronaldson, 2004, Cellular localization and functional expression of P-glycoprotein in rat astrocyte cultures, J Neurochem., 89, 788, 10.1111/j.1471-4159.2004.02417.x Ronaldson, 2006, HIV-1 viral envelope glycoprotein gp120 triggers an inflammatory response in cultured rat astrocytes and regulates the functional expression of P-glycoprotein, Mol Pharmacol., 70, 1087, 10.1124/mol.106.025973 Ronaldson, 2008, HIV-1 viral envelope glycoprotein gp120 produces oxidative stress and regulates the functional expression of multidrug resistance protein-1 (Mrp1) in glial cells, J Neurochem., 106, 1298, 10.1111/j.1471-4159.2008.05479.x Rosenberg, 2012, Neurological diseases in relation to the blood-brain barrier, J Cereb Blood Flow Metab., 32, 1139, 10.1038/jcbfm.2011.197 Salvamoser, 2015, Glutamate-Mediated Down-Regulation of the Multidrug-Resistance Protein BCRP/ABCG2 in Porcine and Human Brain Capillaries, Mol Pharm., 10.1021/mp500841w Schinelli, 2006, Pharmacology and physiopathology of the brain endothelin system: an overview, Curr Med Chem., 13, 627, 10.2174/092986706776055652 Selkoe, 2001, Alzheimer׳s disease: genes, proteins, and therapy, Physiol Rev., 81, 741, 10.1152/physrev.2001.81.2.741 Sharom, 2008, ABC multidrug transporters: structure, function and role in chemoresistance, Pharmacogenomics, 9, 105, 10.2217/14622416.9.1.105 Siddiqui, 2003, Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1, N Engl J Med., 348, 1442, 10.1056/NEJMoa021986 Sills, 2005, Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment, Epilepsia, 46, 643, 10.1111/j.1528-1167.2005.46304.x Sisodiya, 1999, Over-expression of P-glycoprotein in malformations of cortical development, Neuroreport, 10, 3437, 10.1097/00001756-199911080-00032 Tai, 2009, P-glycoprotein and breast cancer resistance protein restrict apical-to-basolateral permeability of human brain endothelium to amyloid-beta, J Cereb Blood Flow Metab., 29, 1079, 10.1038/jcbfm.2009.42 Tan, 2004, Failure to confirm association of a polymorphism in ABCB1 with multidrug-resistant epilepsy, Neurology, 63, 1090, 10.1212/01.WNL.0000137051.33486.C7 Tishler, 1995, MDR1 gene expression in brain of patients with medically intractable epilepsy, Epilepsia, 36, 1, 10.1111/j.1528-1157.1995.tb01657.x Toth, 1996, MDR1 P-glycoprotein is expressed by endothelial cells of newly formed capillaries in human gliomas but is not expressed in the neovasculature of other primary tumors, Am J Pathol., 149, 853 Truelsen, 2009, The worldwide burden of stroke: current status and future projections, Handb Clin Neurol, 92, 327, 10.1016/S0072-9752(08)01916-7 Ueno, 2009, The expression of P-glycoprotein is increased in vessels with blood-brain barrier impairment in a stroke-prone hypertensive model, Neuropathol Appl Neurobiol., 35, 147, 10.1111/j.1365-2990.2008.00966.x van Assema, 2012, Blood-brain barrier P-glycoprotein function in Alzheimer׳s disease, Brain, 135, 181, 10.1093/brain/awr298 van Os, 2009, Schizophrenia, Lancet, 374, 635, 10.1016/S0140-6736(09)60995-8 van Vliet, 2006, Inhibition of the multidrug transporter P-glycoprotein improves seizure control in phenytoin-treated chronic epileptic rats, Epilepsia, 47, 672, 10.1111/j.1528-1167.2006.00496.x van Vliet, 2010, COX-2 inhibition controls P-glycoprotein expression and promotes brain delivery of phenytoin in chronic epileptic rats, Neuropharmacology, 58, 404, 10.1016/j.neuropharm.2009.09.012 Vasiliou, 2009, Human ATP-binding cassette (ABC) transporter family, Hum Genomics, 3, 281, 10.1186/1479-7364-3-3-281 Vogelgesang, 2002, Deposition of Alzheimer׳s beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans, Pharmacogenetics, 12, 535, 10.1097/00008571-200210000-00005 Vogelgesang, 2006, Cerebrovascular P-glycoprotein expression is decreased in Creutzfeldt-Jakob disease, Acta Neuropathol., 111, 436, 10.1007/s00401-006-0042-3 Volk, 2005, Immunohistochemical localization of P-glycoprotein in rat brain and detection of its increased expression by seizures are sensitive to fixation and staining variables, J Histochem Cytochem., 53, 517, 10.1369/jhc.4A6451.2005 von Wedel-Parlow, 2009, Regulation of major efflux transporters under inflammatory conditions at the blood-brain barrier in vitro, J Neurochem., 111, 111, 10.1111/j.1471-4159.2009.06305.x Wang, 2012, Brain distribution of cediranib is limited by active efflux at the blood-brain barrier, J Pharmacol Exp Ther., 341, 386, 10.1124/jpet.111.190488 Wang, 2010, Constitutive androstane receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier, Mol Pharmacol., 78, 376, 10.1124/mol.110.063685 Wang, 2011, Aryl hydrocarbon receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier, FASEB J, 25, 644, 10.1096/fj.10-169227 Wang, 2011, Activating PKC-beta1 at the blood-brain barrier reverses induction of P-glycoprotein activity by dioxin and restores drug delivery to the CNS, J Cereb Blood Flow Metab., 31, 1371, 10.1038/jcbfm.2011.44 Wang, 2014, Nrf2 upregulates ATP binding cassette transporter expression and activity at the blood-brain and blood-spinal cord barriers, J Neurosci., 34, 8585, 10.1523/JNEUROSCI.2935-13.2014 Weiss, 2009, The blood-brain barrier in brain homeostasis and neurological diseases, Biochim Biophys Acta., 1788, 842, 10.1016/j.bbamem.2008.10.022 Wellenius, 2005, Air pollution and hospital admissions for ischemic and hemorrhagic stroke among medicare beneficiaries, Stroke, 36, 2549, 10.1161/01.STR.0000189687.78760.47 Westerlund, 2008, Expression of multi-drug resistance 1 mRNA in human and rodent tissues: reduced levels in Parkinson patients, Cell Tissue Res., 334, 179, 10.1007/s00441-008-0686-5 Wijesuriya, 2010, ABC efflux transporters in brain vasculature of Alzheimer׳s subjects, Brain Res., 1358, 228, 10.1016/j.brainres.2010.08.034 Wolf, 2012, ABC Transporters and the Alzheimer׳s Disease Enigma, Front Psychiatry, 3, 54, 10.3389/fpsyt.2012.00054 Wong, 2013, The blood-brain barrier: an engineering perspective, Front Neuroeng, 6, 7, 10.3389/fneng.2013.00007 Xiong, 2009, ABCG2 is upregulated in Alzheimer׳s brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides, J Neurosci., 29, 5463, 10.1523/JNEUROSCI.5103-08.2009 You, 2006, 1 Yousif, 2007, Expression of drug transporters at the blood-brain barrier using an optimized isolated rat brain microvessel strategy, Brain Res., 1134, 1, 10.1016/j.brainres.2006.11.089 Yousif, 2012, Induction of P-glycoprotein and Bcrp at the rat blood-brain barrier following a subchronic morphine treatment is mediated through NMDA/COX-2 activation, J Neurochem., 123, 491, 10.1111/j.1471-4159.2012.07890.x Zastre, 2009, Up-regulation of P-glycoprotein by HIV protease inhibitors in a human brain microvessel endothelial cell line, J Neurosci Res., 87, 1023, 10.1002/jnr.21898 Zembruski, 2011, Potential of novel antiretrovirals to modulate expression and function of drug transporters in vitro, J Antimicrob Chemother., 66, 802, 10.1093/jac/dkq501 Zhang, 2003, The expression and functional characterization of ABCG2 in brain endothelial cells and vessels, FASEB J, 17, 2085, 10.1096/fj.02-1131fje Zhao, 2002, Shiga-like toxin II modifies brain distribution of a P-glycoprotein substrate, doxorubicin, and P-glycoprotein expression in mice, Brain Res., 956, 246, 10.1016/S0006-8993(02)03546-1 Zhou, 2008, Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development, Curr Med Chem., 15, 1981, 10.2174/092986708785132870 Zhu, 2004, Glutamate up-regulates P-glycoprotein expression in rat brain microvessel endothelial cells by an NMDA receptor-mediated mechanism, Life Sci., 75, 1313, 10.1016/j.lfs.2004.02.027 Zibell, 2009, Prevention of seizure-induced up-regulation of endothelial P-glycoprotein by COX-2 inhibition, Neuropharmacology, 56, 849, 10.1016/j.neuropharm.2009.01.009 Zlokovic, 2008, The blood-brain barrier in health and chronic neurodegenerative disorders, Neuron, 57, 178, 10.1016/j.neuron.2008.01.003 Zschiedrich, 2009, MDR1 variants and risk of Parkinson disease. Association with pesticide exposure?, J Neurol, 256, 115, 10.1007/s00415-009-0089-x